Phase
Condition
Prostate Disorders
Prostate Cancer, Early, Recurrent
Prostate Cancer
Treatment
SpaceOAR Vue
BioProtect Balloon Implant System
Clinical Study ID
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Subjects greater than 18 years old with prostate cancer
Subjects must have histologically confirmed adenocarcinoma of the prostate with biopsy taken within 12 months and must be planned to undergo proton beam therapy with rectal spacer
Subjects must have clinical stage T1-T3 with no posterior extra capsular extension of the prostate cancer
PSA less than or equal to 20 ng/mL
Gleason Score less than or equal to 7
Capacity to comprehend and readiness to sign a written informed consent form
Exclusion Criteria
Planned Pelvic lymph node radiotherapy.
Metastatic disease.
Prior local prostate cancer therapy
Active Inflammatory bowel disease requiring treatment with steroids.
Prior radical prostatectomy.
Active urinary tract infection.
Acute or chronic inflammation or infection of the prostate.
Study Design
Connect with a study center
Procure Proton Therapy Center
Somerset, New Jersey 08873
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.